Sale

8 stories about Sale
רוני על דור  נשיא ומנכל סאפיינס

Israeli insurtech company Sapiens, valued at nearly $2 billion, eyes sale

06.04.24|Reuters
Sapiens started exploring a sale after attracting takeover interest last summer and put its plans on hold after the outbreak of the war between Israel and Hamas. The company revived its efforts to sell itself a few weeks ago
שגית מלכס ו אמיתי תמיר

Walnut appoints Sagit Malkes Glaswein and Amitai Tamir to executive positions

13.02.22|CTech
The pair are joining the company from Similarweb and Gett to serve as VP People & Operations and VP Finance
default image

What motivates employees? Clearly it isn’t internal competition

10.02.21|Maayan Manela
Less than 20% of salespeople improve their work performance through competition, while most prefer short-term challenges, finds startup Enerjoy that uses AI to measure employee motivation
מנכ"ל מאסיבית ארז צימרמן בתוך מדפסת של החברה

Going Big: Israeli 3D printing company signs $80 million deal with Italy’s Biesse Group

01.11.20|Meir Orbach
MASSIVit 3D, the maker of large-format three-dimensional printers expects to sell 20-40 new machines a year
ג'ו מונטנה שחקן פוטבול לשעבר משקיע הייטק ינואר 2019

Joe Montana among seed investors in Israeli startup Walnut

06.10.20|Meir Orbach
The company, which is also backed by NFX, aims to provide sales teams with a fully customizable demo platform
תורים בפתיחת חנות שיאומי דיזנגוף סנטר 22.8.18

Israeli Customers Stormed Xiaomi’s Tel Aviv Store Opening

23.08.18|Tofi Stoler
Thousands of customers clamored to get into the store, and security was beefed up. Discounted items were sold out in little over an hour
default image

London, Toronto, Singapore Eyeing The Tel Aviv Stock Exchange

27.02.18|Golan Hazani
In January, the exchange announced its intention to sell 71% of its shares for around $147 million, following a 2017 parliamentary reform
מטה טבע פתח תקווה

Allergan Planning Sale of its Teva Stock

01.11.17|Dror Reich and Lilach Baumer
For the third quarter of 2017, Allergan reported an operating loss of $4.02 billion, $1.3 billion of which is due to the depreciation of its Teva securities.